Feingold A
Anesth Analg. 1977 Sep-Oct;56(5):622-6. doi: 10.1213/00000539-197709000-00005.
Sequential determinations of halothane blood solubility were determined in 8 patients undergoing cardiac surgical procedures with cardiopulmonary bypass (CPB), hypothermia, and crystalloid hemodilution. The mean temperature-corrected blood/gas partition coefficient (B/G) at the end of surgery (2.4) was lower than preceding induction (2.7). The greatest mean B/G (2.9) occurred after induction of anesthesia. The halothane B/G did not increase significantly at the inception of CPB but decreased from a mean 2.7 to 1.6 as the patients were rewarmed. The maximum range of B/G for a single patient was 1.4 to 3.1. For halothane, the increased blood solubility due to hypothermia was initially antagonized by the crystalloid hemodilution. This antagonism would also be anticipated for methoxyflurane, enflurane, and isoflurane. For N2O and diethyl ether, the increased blood solubility due to hypothermia would be unopposed by simultaneous crystalloid hemodilution.
对8例接受体外循环(CPB)、低温和晶体液血液稀释的心脏手术患者进行了氟烷血液溶解度的连续测定。手术结束时平均经温度校正的血液/气体分配系数(B/G)(2.4)低于诱导前(2.7)。最大平均B/G(2.9)出现在麻醉诱导后。CPB开始时氟烷B/G没有显著增加,但随着患者复温,从平均2.7降至1.6。单个患者的B/G最大范围为1.4至3.1。对于氟烷,低温导致的血液溶解度增加最初被晶体液血液稀释所拮抗。这种拮抗作用对甲氧氟烷、恩氟烷和异氟烷也可预期。对于N2O和乙醚,低温导致的血液溶解度增加不会被同时进行的晶体液血液稀释所抵消。